Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GYKI 52466' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 137 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Grasso, S; De Sarro, G; De Sarro, A; Micale, N; Polimeni, S; Zappala, M; Puia, G; Baraldi, M; De Micheli, C
      Synthesis and anticonvulsant activity of novel and potent 1-aryl-7,8-methylenedioxy-1,2,3,5-tetrahydro-4H-2,3-benzodiazepin-4-ones

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    2. Welch, WM; Ewing, FE; Huang, J; Menniti, FS; Pagnozzi, MJ; Kelly, K; Seymour, PA; Guanowsky, V; Guhan, S; Guinn, MR; Critchett, D; Lazzaro, J; Ganong, AH; DeVries, KM; Staigers, TL; Chenard, BL
      Atropisomeric quinazolin-4-one derivatives are potent noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    3. Szabados, T; Gigler, G; Gacsalyi, I; Gyertyan, I; Levay, G
      Comparison of anticonvulsive and acute neuroprotective activity of three 2,3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655

      BRAIN RESEARCH BULLETIN
    4. Horvath, K
      Highlights of CNS research at IDR: 2,3-benzodiazepines

      PHARMAZIE
    5. Rogawski, MA; Kurzman, PS; Yamaguchi, S; Li, H
      Role of AMPA and GluR5 kainate receptors in the development and expressionof amygdala kindling in the mouse

      NEUROPHARMACOLOGY
    6. Dai, WM; Egebjerg, J; Lambert, JDC
      Characteristics of AMPA receptor-mediated responses of cultured cortical and spinal cord neurones and their correlation to the expression of glutamate receptor subunits, GluR1-4

      BRITISH JOURNAL OF PHARMACOLOGY
    7. Kristensen, BW; Noraberg, J; Zimmer, J
      Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures

      BRAIN RESEARCH
    8. Arai, AC
      GYKI 52466 has positive modulatory effects on AMPA receptors

      BRAIN RESEARCH
    9. Lees, GJ; Leong, W
      In vivo, the direct and seizure-induced neuronal cytotoxicity of kainate and AMPA is modified by the non-competitive antagonist, GYKI 52466

      BRAIN RESEARCH
    10. Rizzo, M
      Chromatographic separation of 2,3-benzodiazepines

      JOURNAL OF CHROMATOGRAPHY B
    11. Abraham, G; Solyom, S; Csuzdi, E; Berzsenyi, P; Ling, I; Tarnawa, I; Hamori, T; Pallagi, I; Horvath, K; Andrasi, F; Kapus, G; Harsing, LG; Kiraly, I; Patthy, M; Horvath, G
      New non competitive AMPA antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY
    12. Kapus, G; Szekely, JI; Durand, J; Ruiz, A; Tarnawa, I
      AMPA receptor antagonists, GYKI 52466 and NBQX, do not block the inductionof long-term potentiation at therapeutically relevant concentrations

      BRAIN RESEARCH BULLETIN
    13. Barna, B; Szasz, A; Vilagi, I; Szente, M
      Anticonvulsive effect of AMPA receptor antagonist GYKI 52466 on 4-aminopyridine-induced cortical ictal activity in rat

      BRAIN RESEARCH BULLETIN
    14. Kessler, M; Rogers, G; Arai, A
      The norbornenyl moiety of cyclothiazide determines the preference for flip-flop variants of AMPA receptor subunits

      NEUROSCIENCE LETTERS
    15. Cotton, JLS; Partin, KM
      The contributions of GluR2 to allosteric modulation of AMPA receptors

      NEUROPHARMACOLOGY
    16. Weiser, T; Iizuka, M; Nishimura, S; Akiba, I; Barsoumian, E; Zhou, M; Steinhauser, C; Brenner, M; Palluk, R; Wienrich, M
      Characterization of the anticonvulsant and neuroprotectant BIIR 561 CL in vitro: effects on native and recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    17. Borowicz, KK; Kleinrok, Z; Czuczwar, SJ
      The AMPA/kainate receptor antagonist, LY 300164, increases the anticonvulsant effects of diazepam

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    18. Menniti, FS; Chenard, BL; Collins, MB; Ducat, MF; Elliott, ML; Ewing, FE; Huang, JI; Kelly, KA; Lazzaro, JT; Pagnozzi, MJ; Weeks, JL; Welch, WM; White, WF
      Characterization of the binding site for a novel class of noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonists

      MOLECULAR PHARMACOLOGY
    19. Grasso, S; De Sarro, G; De Sarro, A; Micale, N; Zappala, M; Puja, G; Baraldi, M; De Micheli, C
      Synthesis and anticonvulsant activity of novel and potent 6,7-methylenedioxyphthalazin-1(2H)-ones

      JOURNAL OF MEDICINAL CHEMISTRY
    20. Kapus, G; Bodi, I; Pataki, G; Gueritaud, JP; Szekely, JI; Tarnawa, I
      Differential modulation of the GYKI 53784-induced inhibition of AMPA currents by various AMPA-positive modulators in cerebellar Purkinje cells

      EUROPEAN JOURNAL OF PHARMACOLOGY
    21. Marinelli, S; Gatta, F; Sagratella, S
      Effects of GYKI 52466 and some 2,3-benzodiazepine derivatives on hippocampal in vitro basal neuronal excitability and 4-aminopyridine epileptic activity

      EUROPEAN JOURNAL OF PHARMACOLOGY
    22. Skradski, S; White, HS
      Topiramate blocks kainate-evoked cobalt influx into cultured neurons

      EPILEPSIA
    23. Chimirri, A; Gitto, R; Zappala, M
      AMPA receptor antagonists

      EXPERT OPINION ON THERAPEUTIC PATENTS
    24. Juhng, KN; Kokate, TG; Yamaguchi, S; Kim, BY; Rogowski, RS; Blaustein, MP; Rogawski, MA
      Induction of seizures by the potent K+ channel-blocking scorpion venom peptide toxins tityustoxin-K alpha and pandinustoxin-K alpha

      EPILEPSY RESEARCH
    25. Nisim, AA; Hernandez, CM; Cohen, RW
      The neuroprotective effects of non-NMDA antagonists in the cerebellum of the spastic Han Wistar mutant

      DEVELOPMENTAL NEUROSCIENCE
    26. Gyertyan, I; Gigler, G; Simo, A
      The neuroprotective and hypothermic effect of GYKI-52466, a non-competitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-antagonist on histological and behavioural variables in the gerbil global ischemia model

      BRAIN RESEARCH BULLETIN
    27. Doczi, J; Banczerowski-Pelyhe, I; Barna, B; Vilagi, I
      Effect of a glutamate receptor antagonist (GYKI 52466) on 4-aminopyridine-induced seizure activity developed in rat cortical slices

      BRAIN RESEARCH BULLETIN
    28. Phillis, JW; Song, D; Guyot, LL; O'Regan, MH
      Failure of kynurenic acid to inhibit amino acid release from the ischemic rat cerebral cortex

      NEUROSCIENCE LETTERS
    29. Gray, A; Allison, C; Pratt, JA
      A role for AMPA kainate receptors in conditioned place preference induced by diazepam in the rat

      NEUROSCIENCE LETTERS
    30. May, PC; Robison, PM; Fuson, KS
      Stereoselective neuroprotection by novel 2,3-benzodiazepine noncompetitiveAMPA antagonists against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures

      NEUROSCIENCE LETTERS
    31. Barna, B; Szente, M; Szasz, A
      The anticonvulsive effect of non-NMDA antagonist GYKI 52466 on 3-aminopyridine-induced primary and secondary cortical ictal activity in rat

      ACTA BIOLOGICA HUNGARICA
    32. Chi, OZ; Chang, Q; Wang, GL; Liu, X; Weiss, HR
      A nonNMDA antagonist, GYKI52466 improves microscopic O-2 balance in the cortex during focal cerebral ischemia

      NEUROLOGICAL RESEARCH
    33. De Sarro, G; Rizzo, M; Spagnolo, C; Gitto, R; De Sarro, A; Scotto, G; Zappala, M; Chimirri, A
      Anticonvulsant activity and plasma level of 2,3-benzodiazepin-4-ones (CFMs) in genetically epilepsy-prone rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    34. Schielke, GP; Kupina, NC; Boxer, PA; Bigge, CF; Welty, DF
      The neuroprotective effect of the novel AMPA receptor antagonist PD152247 (PNQX) in temporary focal ischemia in the rat

      STROKE
    35. Mead, AN; Stephens, DN
      CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: A role for the glycine site of the NMDA receptor, but notAMPA receptors

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    36. Weiser, T; Brenner, M; Palluk, R; Bechtel, WD; Ceci, A; Brambilla, A; Ensinger, HA; Sagrada, A; Wienrich, M
      BIIR 561 CL: A novel combined antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with anticonvulsive and neuroprotective properties

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    37. Grasso, S; De Sarro, G; De Sarro, A; Micale, N; Zappala, M; Puia, G; Baraldi, M; De Micheli, C
      Synthesis and anticonvulsant activity of novel and potent 2,3-benzodiazepine AMPA/kainate receptor antagonists

      JOURNAL OF MEDICINAL CHEMISTRY
    38. De Sarro, A; De Sarro, G; Gitto, R; Grasso, S; Micale, N; Zappala, M
      Synthesis and anticonvulsant activity of new 2,3-benzodiazepines as AMPA receptor antagonists

      FARMACO
    39. Borowicz, KK; Luszczki, J; Szadkowski, M; Kleinrok, Z; Czuczwar, SJ
      Influence of LY 300164, an antagonist of AMPA/kainate receptors, on the anticonvulsant activity of clonazepam

      EUROPEAN JOURNAL OF PHARMACOLOGY
    40. De Sarro, G; Di Paola, ED; Gareri, P; Gallelli, L; Scotto, G; De Sarro, A
      Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    41. Sinha, AK; Mirza, AH; Liu, X; Chi, OZ; Weiss, HR
      Effect of upregulation of AMPA glutamate receptors on cerebral O-2 consumption and blood flow in rat

      BRAIN RESEARCH
    42. RIZZO M; SINOPOLI VA; GITTO R; ZAPPALA M; DESARRO G; CHIMIRRI A
      HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF NEW 2,3-BENZODIAZEPINES

      Journal of chromatography B. Biomedical sciences and applications
    43. CZUCZWAR SJ; GASIOR M; KAMINSKI R; KLEINROK Z; KOZICKA M; OSSOWSKA G; PIETRASIEWICZ T
      GYKI-52466 4-METHOXY-7,8-METHYLENEDIOXY-5H-2,3-BENZODIAZEPINE HYDROCHLORIDE] AND THE ANTICONVULSIVE ACTIVITY OF CONVENTIONAL ANTIEPILEPTICSAGAINST PENTETRAZOL IN MICE

      Molecular and chemical neuropathology
    44. DESARRO A; DESARRO G; GITTO R; GRASSO S; MICALE N; QUARTARONE S; ZAPPALA M
      7,8-METHYLENEDIOXY-4H-2,3-BENZODIAZEPIN-4-ONES AS NOVEL AMPA RECEPTORANTAGONISTS

      Bioorganic & medicinal chemistry letters
    45. Tarnawa, I; Vizi, ES
      2,3-Benzodiazepine AMPA antagonists

      RESTORATIVE NEUROLOGY AND NEUROSCIENCE
    46. ERDO F; ERDO SL
      BIMOCLOMOL PROTECTS AGAINST VASCULAR CONSEQUENCES OF EXPERIMENTAL SUBARACHNOID HEMORRHAGE IN RATS

      Brain research bulletin
    47. DESARRO G; RIZZO M; SINOPOLI VA; GITTO R; DESARRO A; ZAPPALA M; CHIMIRRI A
      RELATIONSHIP BETWEEN ANTICONVULSANT ACTIVITY AND PLASMA-LEVEL OF SOME2,3-BENZODIAZEPINES IN GENETICALLY EPILEPSY-PRONE RATS

      Pharmacology, biochemistry and behavior
    48. ONEILL MJ; BOND A; ORNSTEIN PL; WARD MA; HICKS CA; HOO K; BLEAKMAN D; LODGE D
      DECAHYDROISOQUINOLINES - NOVEL COMPETITIVE AMPA KAINATE ANTAGONISTS WITH NEUROPROTECTIVE EFFECTS IN GLOBAL CEREBRAL-ISCHEMIA/

      Neuropharmacology
    49. RAMMES G; SWANDULLA D; SPIELMANNS P; PARSONS CG
      INTERACTIONS OF GYKI-52466 AND NBQX WITH CYCLOTHIAZIDE AT AMPA RECEPTORS - EXPERIMENTS WITH OUTSIDE-OUT PATCHES AND EPSCS IN HIPPOCAMPAL-NEURONS

      Neuropharmacology
    50. CHIMIRRI A; DESARRO G; DESARRO A; GITTO R; QUARTARONE S; ZAPPALA M; CONSTANTI A; LIBRI V
      3,5-DIHYDRO-4H-2,3-BENZODIAZEPINE-4-THIONES - A NEW CLASS OF AMPA RECEPTOR ANTAGONISTS

      Journal of medicinal chemistry
    51. MATHIESEN C; VARMING T; JENSEN LH
      IN-VIVO AND IN-VITRO EVALUATION OF AMPA RECEPTOR ANTAGONISTS IN RAT HIPPOCAMPAL-NEURONS AND CULTURED MOUSE CORTICAL-NEURONS

      European journal of pharmacology
    52. IBARROLA D; SEEGERS H; JAILLARD A; HOMMEL M; DECORPS M; MASSARELLI R
      THE EFFECT OF ELIPRODIL ON THE EVOLUTION OF A FOCAL CEREBRAL-ISCHEMIAIN-VIVO

      European journal of pharmacology
    53. TANG P; LIACHENKO S; MELICK JA; XU Y
      [P-31] [H-1] NUCLEAR-MAGNETIC-RESONANCE STUDY OF MITIGATING EFFECTS OF GYKI-52466 ON KAINATE-INDUCED METABOLIC IMPAIRMENT IN PERFUSED RAT CEREBROCORTICAL SLICES/

      Epilepsia
    54. KESSLER M; MUTNEJA MS; ROGERS G; LYNCH G
      REGIONAL PREFERENCES OF AMPA RECEPTOR MODULATORS DETERMINED THROUGH AGONIST BINDING AUTORADIOGRAPHY

      Brain research
    55. LUTFY K; CAI SX; WOODWARD RM; WEBER E
      ANTINOCICEPTIVE EFFECTS OF NMDA AND NON-NMDA RECEPTOR ANTAGONISTS IN THE TAIL-FLICK TEST IN MICE

      Pain
    56. OHNO K; OKADA M; TSUTSUMI R; KOHARA A; YAMAGUCHI T
      KAINATE EXCITOTOXICITY IS MEDIATED BY AMPA-PREFERRING BUT NOT KAINATE-PREFERRING RECEPTORS IN EMBRYONIC RAT HIPPOCAMPAL CULTURES

      Neurochemistry international
    57. TZSCHENTKE TM; SCHMIDT WJ
      INTERACTIONS OF MK-801 AND GYKI-52466 WITH MORPHINE AND AMPHETAMINE IN-PLACE PREFERENCE CONDITIONING AND BEHAVIORAL SENSITIZATION

      Behavioural brain research
    58. VIZI ES; MIKE A; TARNAWA I
      THE FUNCTIONAL-STUDY OF KAINATE RECEPTORS - HOPES AND DOUBTS

      Trends in neurosciences
    59. GASIOR M; BOROWICZ K; KLEINROK Z; STAROWNIK R; CZUCZWAR SJ
      ANTICONVULSANT AND ADVERSE-EFFECTS OF MK-801, LY-235959, AND GYKI-52466 IN COMBINATION WITH CA2+ CHANNEL INHIBITORS IN MICE

      Pharmacology, biochemistry and behavior
    60. MARES P; MIKULECKA A; POMETLOVA M
      ANTICONVULSAN ACTION OF -DIHYDROXY-6-NITRO-7-SULFAMOYL-BENZO(F)QUINOXALINE IN IMMATURE WATS - COMPARISON WITH THE EFFECTS ON MOTOR-PERFORMANCE

      The Journal of pharmacology and experimental therapeutics
    61. TORTORELLA A; HALONEN T; SAHIBZADA N; GALE K
      A CRUCIAL ROLE OF THE LPHA-AMINO-3-HYDROXY-5-METHYLISOXAZOLE-4-PROPIONIC ACID SUBTYPE OF GLUTAMATE RECEPTORS IN PIRIFORM AND PERIRHINAL CORTEX FOR THE INITIATION AND PROPAGATION OF LIMBIC MOTOR SEIZURES

      The Journal of pharmacology and experimental therapeutics
    62. CHIMIRRI A; DESARRO G; DESARRO A; GITTO R; GRASSO S; QUARTARONE S; ZAPPALA M; GIUSTI P; LIBRI V; CONSTANTI A; CHAPMAN AG
      1-ARYL-3,5-DIHYDRO-4H-2,3-BENZODIAZEPIN-4-ONES - NOVEL AMPA RECEPTOR ANTAGONISTS

      Journal of medicinal chemistry
    63. SZEKELY JI; KEDVES R; MATE I; TOROK K; TARNAWA I
      APPARENT ANTINOCICEPTIVE AND ANTIINFLAMMATORY EFFECTS OF GYKI52466

      European journal of pharmacology
    64. KUBOVA H; VILAGI I; MIKULECKA A; MARES P
      NON-NMDA RECEPTOR ANTAGONIST GYKI-52466 SUPPRESSES CORTICAL AFTERDISCHARGES IN IMMATURE RATS

      European journal of pharmacology
    65. KOVACS AD; SZABO G
      GYKI-53655, A 2,3-BENZODIAZEPINE, NONCOMPETITIVELY PROTECTS CULTURED NEURONS AGAINST AMPA TOXICITY

      European journal of pharmacology
    66. SCHMIDT WJ; SCHUSTER G; WACKER E; PERGANDE G
      ANTIPARKINSONIAN AND OTHER MOTOR EFFECTS OF FLUPIRTINE ALONE AND IN COMBINATION WITH DOPAMINERGIC DRUGS

      European journal of pharmacology
    67. DURMULLER N; GRAHAM JL; SOWINSKI P; MELDRUM BS
      THE VITAL DYE EVANS BLUE MIMICS LIMBIC SEIZURES INDUCED BY KAINATE ORPILOCARPINE

      Brain research
    68. JAW SP; NGUYEN B; VUONG QTV; TRINH TA; NGUYEN M; TRUONG DD
      EFFECTS OF GLUTAMATE-RECEPTOR ANTAGONISTS ON POSTHYPOXIC MYOCLONUS INRATS

      Brain research bulletin
    69. WEISER T; HERRMANN A; WIENRICH M
      INTERACTIONS OF THE DYE EVANS-BLUE AND GYKI-52466, A 2,3-BENZODIAZEPINE, WITH LPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID RECEPTORS IN CULTURED RAT CORTICAL-NEURONS - ELECTROPHYSIOLOGICAL EVIDENCE FOR AT LEAST 2 DIFFERENT BINDING-SITES FOR NONCOMPETITIVE ANTAGONISTS

      Neuroscience letters
    70. TUTKA P; TURSKI WA; KLEINROK Z; CZUCZWAR SJ
      INFLUENCE OF AMINOPHYLLINE AND STRYCHNINE ON THE PROTECTIVE ACTIVITY OF EXCITATORY AMINO-ACID ANTAGONISTS AGAINST MAXIMAL ELECTROSHOCK-INDUCED CONVULSIONS IN MICE

      Journal of neural transmission
    71. DESARRO G; NAVA F; AGUGLIA U; DESARRO A
      LAMOTRIGINE POTENTIATES THE ANTISEIZURE ACTIVITY OF SOME ANTICONVULSANTS IN DBA 2 MICE/

      Neuropharmacology
    72. LODGE D; BOND A; ONEILL MJ; HICKS CA; JONES MG
      STEREOSELECTIVE EFFECTS OF 2,3-BENZODIAZEPINES IN-VIVO - ELECTROPHYSIOLOGY AND NEUROPROTECTION STUDIES

      Neuropharmacology
    73. BLEAKMAN D; BALLYK BA; SCHOEPP DD; PALMER AJ; BATH CP; SHARPE EF; WOOLLEY ML; BUFTON HR; KAMBOJ RK; TARNAWA I; LODGE D
      ACTIVITY OF 2,3-BENZODIAZEPINES AT NATIVE RAT AND RECOMBINANT HUMAN GLUTAMATE RECEPTORS IN-VITRO - STEREOSPECIFICITY AND SELECTIVITY PROFILES

      Neuropharmacology
    74. BLOCK F; SCHMITT W; SCHWARZ M
      PRETREATMENT BUT NOT POSTTREATMENT WITH GYKI-52466 REDUCES FUNCTIONALDEFICITS AND NEURONAL DAMAGE AFTER GLOBAL-ISCHEMIA IN RATS

      Journal of the neurological sciences
    75. PELLETIER JC; HESSON DP; JONES KA; COSTA AM
      SUBSTITUTED 1,2-DIHYDROPHTHALAZINES - POTENT, SELECTIVE, AND NONCOMPETITIVE INHIBITORS OF THE AMPA RECEPTOR

      Journal of medicinal chemistry
    76. ORNSTEIN PL; ARNOLD MB; ALLEN NK; BLEISCH T; BORROMEO PS; LUGAR CW; LEANDER JD; LODGE D; SCHOEPP DD
      STRUCTURE-ACTIVITY STUDIES OF 6-(TETRAZOLYLALKYL)-SUBSTITUTED DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID AMPA RECEPTOR ANTAGONISTS .1. EFFECTSOF STEREOCHEMISTRY, CHAIN-LENGTH, AND CHAIN SUBSTITUTION

      Journal of medicinal chemistry
    77. WRATHALL JR; TENG YD; CHOINIERE D
      AMELIORATION OF FUNCTIONAL DEFICITS FROM SPINAL-CORD TRAUMA WITH SYSTEMICALLY ADMINISTERED NBQX, AN ANTAGONIST OF NON-N-METHYL-D-ASPARTATE RECEPTORS

      Experimental neurology
    78. OKADA M; KOHARA A; YAMAGUCHI T
      CHARACTERIZATION OF YM90K, A SELECTIVE AND POTENT ANTAGONIST OF AMPA RECEPTORS, IN RAT CORTICAL MESSENGER-RNA-INJECTED XENOPUS OOCYTES

      European journal of pharmacology
    79. TZSCHENTKE TM; SCHMIDT WJ
      MORPHINE-INDUCED CATALEPSY IS AUGMENTED BY NMDA RECEPTOR ANTAGONISTS,BUT IS PARTIALLY ATTENUATED BY AN AMPA RECEPTOR ANTAGONIST

      European journal of pharmacology
    80. RAMMES G; SWANDULLA D; COLLINGRIDGE GL; HARTMANN S; PARSONS CG
      INTERACTIONS OF 2,3-BENZODIAZEPINES AND CYCLOTHIAZIDE AT AMPA RECEPTORS - PATCH-CLAMP RECORDINGS IN CULTURED NEURONS AND AREA CA1 IN HIPPOCAMPAL SLICES

      British Journal of Pharmacology
    81. STRAHLENDORF JC; ACOSTA S; STRAHLENDORF HK
      DIAZOXIDE AND CYCLOTHIAZIDE CONVERT AMPA-INDUCED DARK CELL DEGENERATION OF PURKINJE-CELLS TO EDEMATOUS DAMAGE IN THE CEREBELLAR SLICE

      Brain research
    82. JACKSON A; BROWN G; STEPHENS DN
      N-METHYL-D-ASPARTATE (NMDA) AND HA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPRIONATE (AMPA) GLUTAMATE-RECEPTOR ANTAGONISTS HAVE DIFFERENT INTERACTIONS WITH THE DISCRIMINATIVE STIMULI OF ABUSED DRUGS

      Psychopharmacology
    83. ECKSTEIN JA; SWANSON SP
      DETERMINATION OF A NOVEL PHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONATE RECEPTOR ANTAGONIST (LY300164) AND ITS N-ACETYL METABOLITE IN MOUSE, RAT, DOG, AND MONKEY PLASMA USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION

      Journal of chromatography B. Biomedical applications
    84. SLUSHER BS; RISSOLO KC; ANZILOTTI KF; JACKSON PF
      CENTRALLY-ADMINISTERED AMPA ANTAGONISTS INCREASE LOCOMOTION IN PARKINSONIAN RATS

      Journal of neural transmission. Parkinson's disease and dementia section
    85. HOLTZCLAW LA; GALLO V; RUSSELL JT
      AMPA RECEPTORS SHAPE CA2-4 CELLS( RESPONSES IN CORTICAL OLIGODENDROCYTE PROGENITORS AND CG)

      Journal of neuroscience research
    86. BUBSER M; TZSCHENTKE T; HAUBER W
      BEHAVIORAL AND NEUROCHEMICAL INTERACTIONS OF THE AMPA ANTAGONIST GYKI-52466 AND THE NONCOMPETITIVE NMDA ANTAGONIST DIZOCILPINE IN RATS

      Journal of neural transmission
    87. VELISEK L; KUBOVA H; MARES P; VACHOVA D
      KAINATE AMPA RECEPTOR ANTAGONISTS ARE ANTICONVULSANT AGAINST THE TONIC HINDLIMB COMPONENT OF PENTYLENETETRAZOL-INDUCED SEIZURES IN DEVELOPING RATS

      Pharmacology, biochemistry and behavior
    88. SCHOEPP DD; LODGE D; BLEAKMAN D; LEANDER JD; TIZZANO JP; WRIGHT RA; PALMER AJ; SALHOFF CR; ORNSTEIN PL
      IN-VITRO AND IN-VIVO ANTAGONISM OF AMPA RECEPTOR ACTIVATION BY ZOLE-5-YL)ETHYL]DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID

      Neuropharmacology
    89. RENARD A; CREPEL F; AUDINAT E
      EVIDENCE FOR 2 TYPES OF NON-NMDA RECEPTORS IN RAT CEREBELLAR PURKINJE-CELLS MAINTAINED IN SLICE CULTURES

      Neuropharmacology
    90. JOHANSEN TH; CHAUDHARY A; VERDOORN TA
      INTERACTIONS AMONG GYKI-52466, CYCLOTHIAZIDE, AND ANIRACETAM AT RECOMBINANT AMPA AND KAINATE RECEPTORS

      Molecular pharmacology
    91. WILDING TJ; HUETTNER JE
      DIFFERENTIAL ANTAGONISM OF LPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID-PREFERRING AND KAINATE-PREFERRING RECEPTORS BY 2,3-BENZODIAZEPINES

      Molecular pharmacology
    92. SWEDBERG MDB; JACOBSEN F; HONORE T
      ANTICONVULSANT, ANXIOLYTIC AND DISCRIMINATIVE EFFECTS OF THE AMPA ANTAGONIST 3-DIHYDROXY-6-NITRO-7-SULFAMOYLBENZO(F)QUINOXALINE (NBQX)

      The Journal of pharmacology and experimental therapeutics
    93. FALLARINO F; GENAZZANI AA; SILLA S; LEPISCOPO MR; CAMICI O; CORAZZI L; NICOLETTI F; FIORETTI MC
      [H-3] ANIRACETAM BINDS TO SPECIFIC RECOGNITION SITES IN BRAIN MEMBRANES

      Journal of neurochemistry
    94. HOYT KR; RAJDEV S; FATTMAN CL; REYNOLDS IJ
      CYCLOTHIAZIDE MODULATES AMPA RECEPTOR-MEDIATED INCREASES IN INTRACELLULAR FREE CA2-BRAIN( AND MG2+ IN CULTURED NEURONS FROM RAT)

      Journal of neurochemistry
    95. DESARRO G; CHIMIRRI A; DESARRO A; GITTO R; GRASSO S; GIUSTI P; CHAPMAN AG
      GYKI-52466 AND RELATED 2,3-BENZODIAZEPINES AS ANTICONVULSANT AGENTS IN DBA 2 MICE/

      European journal of pharmacology
    96. YOSHIYAMA M; ROPPOLO JR; DEGROAT WC
      INTERACTIONS BETWEEN NMDA AND AMPA KAINATE RECEPTORS IN THE CONTROL OF MICTURITION IN THE RAT/

      European journal of pharmacology
    97. ONEILL M; CALDWELL M; EARLEY B; CANNEY M; OHALLORAN A; KELLY J; LEONARD BE; JUNIEN JL
      THE SIGMA-RECEPTOR LIGAND JO-1784 (IGMESINE-HYDROCHLORIDE) IS NEUROPROTECTIVE IN THE GERBIL MODEL OF GLOBAL CEREBRAL-ISCHEMIA

      European journal of pharmacology
    98. BOROWICZ KK; GASIOR M; KLEINROK Z; CZUCZWAR SJ
      THE NONCOMPETITIVE AMPA KAINATE RECEPTOR ANTAGONIST, GYKI-52466, POTENTIATES THE ANTICONVULSANT ACTIVITY OF CONVENTIONAL ANTIEPILEPTICS/

      European journal of pharmacology
    99. FARKAS S; ONO H
      PARTICIPATION OF NMDA AND NON-NMDA EXCITATORY AMINO-ACID RECEPTORS INTHE MEDIATION OF SPINAL REFLEX POTENTIALS IN RATS - AN IN-VIVO STUDY

      British Journal of Pharmacology
    100. MATSUMOTO G; HISAMITSU T; DEGROAT WC
      NON-NMDA GLUTAMATERGIC EXCITATORY TRANSMISSION IN THE DESCENDING-LIMBOF THE SPINOBULBOSPINAL MICTURITION REFLEX PATHWAY OF THE RAT

      Brain research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 17:49:55